Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

211
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
211
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

1.9K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.9K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

172
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
172
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

218
The pathophysiology of pneumonia involves the following steps:
218
Pneumonia IV: Management01:28

Pneumonia IV: Management

300
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
300
Infection01:20

Infection

7.7K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
7.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Pneumococcal membrane particles promote serotype-independent cellular and humoral immunity and protect against pneumococcal colonization.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Identification of immunostimulatory antigens in Group A <i><i>Streptococcus</i></i>-derived vesicles.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Closing the Stable Door on Strangles: Serological Responses of Vaccinated Horses on a Farm Following the Arrival of a New Horse.

Animals : an open access journal from MDPI·2025
Same author

Neutralisation of the Immunoglobulin-Cleaving Activity of <i>Streptococcus equi</i> Subspecies <i>equi</i> IdeE by Blood Sera from Ponies Vaccinated with a Multicomponent Protein Vaccine.

Vaccines·2025
Same author

Impact of SARS-CoV-2 variant mutations on susceptibility to monoclonal antibodies and antiviral drugs: a non-systematic review, April 2022 to October 2024.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2025
Same author

Continued circulation of mpox: an epidemiological and phylogenetic assessment, European Region, 2023 to 2024.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2024

相关实验视频

Updated: Jun 8, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.0K

肺炎 estreptococcus 的流行病学,病原和控制.

Ana Rita Narciso1, Rebecca Dookie1, Priyanka Nannapaneni1

  • 1Department of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Stockholm, Sweden.

Nature reviews. Microbiology
|November 7, 2024
PubMed
概括

肺炎链球菌感染是一个主要的健康威胁. 针对流行病学,致病性和抗生素耐药性的新策略对于控制肺炎球菌疾病至关重要,特别是在未接种疫苗的群体中.

更多相关视频

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
06:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

1.7K
Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
09:12

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Published on: January 17, 2014

12.4K

相关实验视频

Last Updated: Jun 8, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.0K
Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
06:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

1.7K
Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
09:12

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Published on: January 17, 2014

12.4K

科学领域:

  • 微生物学 微生物学
  • 传染性疾病 传染性疾病
  • 疫苗学 疫苗学 疫苗学

背景情况:

  • 肺炎链球菌会导致严重的呼吸道和侵入性疾病.
  • 肺炎球菌联合疫苗减少了儿童的疾病,但增加了非疫苗型感染.
  • 未接种疫苗的人群中的抗生素耐药性和疾病需要新的控制策略.

研究的目的:

  • 审查有关肺炎球菌流行病学,基因组学和病变发生的最新发现.
  • 探索针对肺炎球菌感染的新疗法和预防策略.
  • 为未来肺炎球菌疾病的控制策略提供信息.

主要方法:

  • 对临床数据和致病研究的审查.
  • 对流行病学趋势和基因组数据的分析.
  • 评估疫苗的影响和新出现的耐药性模式.

主要成果:

  • 在未接种疫苗的人群中,非疫苗肺炎球菌类型的感染增加.
  • 新兴的抗生素耐药性构成了治疗挑战.
  • 了解病原学的进步为新疗法提供了潜力.

结论:

  • 新的方法对于对抗Streptococcus pneumoniae至关重要.
  • 利用宿主-病原体相互作用可能导致新的治疗方法.
  • 未来的控制策略需要综合方法,考虑疫苗,耐药性和病原性.